Overview
Gary Mason is a Pediatrics provider in Providence, Rhode Island. Dr. Mason is rated as an Experienced provider by MediFind in the treatment of Gliomatosis Cerebri. His top area of expertise is Gliomatosis Cerebri.
His clinical research consists of co-authoring 26 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Gliomatosis Cerebri.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mark Rosenthal is a Pediatrics provider in Gales Ferry, Connecticut. Dr. Rosenthal is rated as an Advanced provider by MediFind in the treatment of Gliomatosis Cerebri. His top areas of expertise are Gliomatosis Cerebri, HIV/AIDS, and Orchiectomy.
Scott Pomeroy is a Pediatric Neurologist and a Neurologist in Boston, Massachusetts. Dr. Pomeroy is rated as a Distinguished provider by MediFind in the treatment of Gliomatosis Cerebri. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Gliomatosis Cerebri. Dr. Pomeroy is currently accepting new patients.
Rishi Lulla is a Pediatrics provider in Providence, Rhode Island. Dr. Lulla is rated as an Advanced provider by MediFind in the treatment of Gliomatosis Cerebri. His top areas of expertise are Gliomatosis Cerebri, Embryonal Tumor with Multilayered Rosettes, and Neurofibromatosis Type 1 (NF1).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers